DiscoverBioBoss#21 - Jason Meyenburg: CEO, Gemini Therapeutics
#21 - Jason Meyenburg: CEO, Gemini Therapeutics

#21 - Jason Meyenburg: CEO, Gemini Therapeutics

Update: 2020-06-13
Share

Description

Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli.  Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#21 - Jason Meyenburg: CEO, Gemini Therapeutics

#21 - Jason Meyenburg: CEO, Gemini Therapeutics

John Simboli